Genex Pharmaceutical, Inc. engages in the development and production of Reconstituted Bone Xenograft, which is a medical device that accelerates bone healing. The company is headquartered in Tianjin, Tianjin and currently employs 86 full-time employees. The company went IPO on 2006-05-23. The Company’s main business is engaged in producing and distributing Reconstituted Bone Xenograft (RBX). The RBX is a medical device that accelerates bone healing. The firm distributes its medical devices to hospitals as well as other medical device customers that are not hospitals.
Financials in millions USD. Fiscal year is February - January.
Breakdown
TTM
12/31/2007
12/31/2006
12/31/2005
12/31/2004
12/31/2003
Revenue
3
3
2
2
2
1
Revenue Growth (YoY)
50%
50%
0%
0%
100%
--
Cost of Revenue
0
0
0
0
0
0
Gross Profit
2
2
2
2
2
1
Selling, General & Admin
2
2
1
1
1
0
Research & Development
0
0
0
0
0
--
Operating Expenses
2
2
1
1
1
0
Other Non Operating Income (Expenses)
0
0
0
0
0
0
Pretax Income
0
0
1
0
1
0
Income Tax Expense
0
0
0
0
0
0
Net Income
0
0
0
0
1
0
Net Income Growth
--
--
--
-100%
--
--
Shares Outstanding (Diluted)
17.84
17.84
17.84
17.84
17.84
14.63
Shares Change (YoY)
0%
0%
0%
0%
22%
--
EPS (Diluted)
0.01
0.01
0.03
0.03
0.05
0.03
EPS Growth
-50%
-45%
-1%
-38%
84%
--
Free Cash Flow
0
0
1
1
0
0
Free Cash Flow Per Share
--
--
--
--
--
--
Gross Margin
66.66%
66.66%
100%
100%
100%
100%
Operating Margin
0%
0%
0%
0%
0%
0%
Profit Margin
0%
0%
0%
0%
50%
0%
Free Cash Flow Margin
0%
0%
50%
50%
0%
0%
EBITDA
0
0
0
0
0
0
EBITDA Margin
0%
0%
0%
0%
0%
0%
D&A For EBITDA
0
0
0
0
0
0
EBIT
0
0
0
0
0
0
EBIT Margin
0%
0%
0%
0%
0%
0%
Effective Tax Rate
0%
0%
0%
0%
0%
0%
Follow-Up Questions
What are Genex Pharmaceutical Inc's key financial statements?
According to the latest financial statement (Form-10K), Genex Pharmaceutical Inc has a total asset of $8, Net loss of $0
What are the key financial ratios for GENX?
Genex Pharmaceutical Inc's Current ratio is 2.66, has a Net margin is 0, sales per share of $0.16.
How is Genex Pharmaceutical Inc's revenue broken down by segment or geography?
Genex Pharmaceutical Inc largest revenue segment is Tai Er, at a revenue of 4,946,972,057 in the most earnings release.For geography, China is the primary market for Genex Pharmaceutical Inc, at a revenue of 6,614,352,119.
Is Genex Pharmaceutical Inc profitable?
no, according to the latest financial statements, Genex Pharmaceutical Inc has a net loss of $0
Does Genex Pharmaceutical Inc have any liabilities?
yes, Genex Pharmaceutical Inc has liability of 3
How many outstanding shares for Genex Pharmaceutical Inc?
Genex Pharmaceutical Inc has a total outstanding shares of 17.84